GlassScriptPhysician profile
Pattyann A Hardt
NPI 1649443201
$6,264.02
in general payments reported to CMS, 2019-2025
44 companies · $872 in 2025
The $872 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,201 · 2020: $1,076 · 2021: $1,004 · 2022: $1,001 · 2023: $575 · 2024: $534 · 2025: $872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,891.57 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,275.21 | 2019-2025 | |
| Daiichi Sankyo INC. | $690.11 | 2019-2022 | |
| Exeltis, USA INC. | $472.50 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $440.41 | 2020-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $354.24 | 2019-2025 | Myosure Tissue Removal Device |
| Coopersurgical, INC. | $292.10 | 2020-2024 | Summit Doppler |
| Pfizer INC. | $237.26 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $217.81 | 2021-2025 | |
| Therapeuticsmd, INC. | $205.36 | 2019-2022 | |
| Minerva Surgical, INC | $175.91 | 2019-2024 | |
| Biogen, INC. | $169.20 | 2024-2025 | Zurzuvae, Vumerity |
| Millicent US INC | $167.78 | 2020-2025 | Intrarosa, Femlyv, Femring |
| Aspira Women'S Health INC | $145.42 | 2022 | |
| Avion Pharmaceuticals | $134.66 | 2019-2023 | Balcoltra |
| Shield Therapeutics INC | $132.59 | 2023-2024 | Accrufer |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pattyann Hardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.